LONDON, Oct 24 (Reuters) - Abbott Laboratories (ABT.N: Quote, Profile, Research) Humira, Amgen Inc’s (AMGN.O: Quote, Profile, Research) Enbrel and Johnson & Johnson (JNJ.N: Quote, Profile, Research) unit Centocor’s Remicade rheumatoid arthritis drugs were recommended on Wednesday for use in Britain’s state health service.The National Institute for Health and Clinical Excellence (NICE), which assesses the value of medicines in England and Wales, issued guidance for the drugs as options for adults who have unsuccessfully tried two other rheumatoid treatments.
